METHODS OF USING MUSCARINIC ANTAGONISTS IN THE TREATMENT OF DEPRESSION
Muscarinic antagonist are provided that are used in the treatment of depression in a subject, such as humans. The muscarinic antagonist of the invention can relieve depression without effecting cognitive functions in the treated subject.
-
Paragraph 0062
(2020/10/19)
CARBOXAMIDE INHIBITORS OF IRAK4 ACTIVITY
The present invention relates to carboxamide inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
-
(2016/09/26)
DEPENDENCE OF THE M-CHOLINOMIMETIC PROPERTIES OF ARECOLINE ANALOGS ON THE STRUCTURAL PECULIARITIES OF THEIR MOLECULES
-
Kudryashova, N. I.,Losev, N. A.
p. 127 - 130
(2007/10/02)
Structure- and conformation-activity relationships of cyclic acetylcholin analogs of the quinuclidine and piperidine series.
-
Lambrecht,Mutschler
p. 1725,1726
(2007/10/04)
5-hydroxy-3-piperidylidenemethane derivatives as spasmolytics.
-
Kawazu,Kanno,Saito,Tamaki
p. 914 - 918
(2007/10/04)
More Articles about upstream products of 1690-72-8